Bernstein Affirms Market Perform on Qualcomm, $165 Price Target

Sep 25, 2026 Analyst: Stacy Rasgon 1 min read Reproduced verbatim
Rating
Hold
Price target
$165
Implied downside
-15%
vs $194.26 prior close
Bernstein and Qualcomm logos

Bernstein SocGen Group analyst Stacy Rasgon reiterated a Market Perform rating and $165 price target on Qualcomm (NASDAQ: QCOM).

“Renews Apple licensing agreement, hopefully settled? Or kicked down the road again?

This morning Qualcomm announced the renewal of their QTL licensing agreement with AAPL, effective April 1 (when the old agreement was set to expire).

The question of “will they or won’t they” around this issue has been a controversy given the two companies were in dispute about it last time, and given the (non-trivial) impact on Qualcomm’s financials (we estimate ~$1.5-$1.7B in revenue at roughly $7.50ish per phone, and ~$1.25-$1.50 in EPS), so the renewal is, for now, welcome.

Note that numbers broadly incorporated the royalty sticking around.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note−7% QCOM $194.26 → $181.03 (Oct 7) · 45% of the way to the target

This callScored on Mar 27, 2027, six months after the note: did QCOM reach $165?

Firm track recordBernstein reached 75% of its 40 scored targets within six months (#9 of 31 firms); on Qualcomm, 3 of 3. Accuracy ranking →

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.